Please note: The information displayed on this page might be outdated.
Akouos: Restoring and preserving high-acuity hearing is one of the greatest unmet challenges of medicine: 360 million people worldwide have disabling hearing loss, but there are no FDA-approved therapies to address it.
Based in...
US - New England
Public, USA
Market Cap
100MM - 500MM
Boston, MA
United States

Company Participants at Private Company Showcase NYC 2019

  • Greg Robinson, CSO
  • Manny Simons, CEO

Top 10 Holders of Akouos, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Fidelity Management & Research Co. LLC 13.67 4,701,065 54.81 13F 3/31/21
NEA Management Co. 12.49 4,298,488 50.12 13F 3/31/21
5AM Venture Management LLC 12.02 4,135,784 48.22 13F 3/31/21
Federated Global Investment Management Corp. 7.25 2,494,682 29.09 13F 3/31/21
RA Capital Management LP 6.63 2,281,249 26.60 13F 3/31/21
Ecor1 Capital LLC 5.74 1,975,984 23.04 13F 3/31/21
Pivotal Bioventure Partners Investment Advisor LLC 5.22 1,794,088 20.92 13F 3/31/21
Sofinnova Investments, Inc. 4.40 1,515,074 17.67 13F 3/31/21
Citadel LP 3.93 1,351,317 15.76 13F 3/31/21
BlackRock Fund Advisors 3.15 1,083,965 12.64 13F 3/31/21
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2021 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.